BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1530815)

  • 1. Universal hepatitis B vaccination: the economics of prevention.
    Krahn MD; Detsky AS
    CMAJ; 1992 Jan; 146(1):19-21. PubMed ID: 1530815
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1992 Jan; 146(1):25-8. PubMed ID: 1530816
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
    Fernández Barboza R; Rivero D; Echeverría B; Machado IV
    Bol Oficina Sanit Panam; 1991 Jul; 111(1):16-23. PubMed ID: 1834080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of hepatitis B by vaccination in 53 children at risk. Transmission of hepatitis B virus infection and its prevention].
    Zecca G; Motti G; Manzoni C; Del Curto E
    Minerva Pediatr; 1985 Sep; 37(17):593-6. PubMed ID: 2934613
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization procedures for hepatitis infections.
    Truss CD
    Ala J Med Sci; 1985 Jan; 22(1):42-4. PubMed ID: 3156542
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of hepatitis B: to be or not to be?
    Hall CB; Halsey NA
    Pediatrics; 1992 Aug; 90(2 Pt 1):274-7. PubMed ID: 1386421
    [No Abstract]   [Full Text] [Related]  

  • 8. [Forecasting strategies of hepatitis B vaccination based on decision tree model].
    Zhang SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):193-7. PubMed ID: 2509074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
    Ginsberg GM; Berger S; Shouval D
    Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
    Kerleau M; Flori YA; Nalpas B; Lanoé JL; Berthelot P; Fardeau-Gautier M
    Rev Epidemiol Sante Publique; 1995; 43(1):48-60. PubMed ID: 7892516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B vaccination is still current].
    Kremp O
    Soins Pediatr Pueric; 1999; (187):31-2. PubMed ID: 10615148
    [No Abstract]   [Full Text] [Related]  

  • 12. Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early?
    Ganiats TG; Bowersox MT; Ralph LP
    J Fam Pract; 1993 Feb; 36(2):147-9. PubMed ID: 8426132
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
    Schalm SW; Mazel JA; de Gast GC; Heijtink RA; Botman MJ; Bänffer JR; Cerards LJ; Zwijnenberg J; Fetter WP; Nuijten SM
    Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why should Australia adopt universal infant hepatitis B vaccination?
    Thompson SC; Oman K
    Aust N Z J Public Health; 1996 Aug; 20(4):436-9. PubMed ID: 8908772
    [No Abstract]   [Full Text] [Related]  

  • 15. [The costs of hepatitis B vaccination: a re-evaluation].
    van de Ven AA; van Hattum J; Willers JM
    Ned Tijdschr Geneeskd; 1990 Feb; 134(6):298-301. PubMed ID: 2137560
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis B screening in pregnancy and simultaneous postpartum vaccination of newborn infants].
    Sacher M
    Padiatr Padol; 1990; 25(2):111-5. PubMed ID: 2141397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of decision making analysis for evaluating hepatitis B inoculation strategy].
    Zhuang GH; Xu HW
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):69-73. PubMed ID: 8354107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination: a cost analysis.
    Bergus G; Meis S
    Iowa Med; 1995 May; 85(5):209-11. PubMed ID: 7607831
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis].
    Zhang SX
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):154-8. PubMed ID: 1395956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of hepatitis B virus vaccine.
    Chin J
    N Engl J Med; 1982 Sep; 307(11):678-9. PubMed ID: 6810171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.